Literature DB >> 2825960

Macroregenerative nodule of the liver. A clinicopathologic study of 345 autopsy cases of chronic liver disease.

K Furuya1, M Nakamura, Y Yamamoto, K Togei, H Otsuka.   

Abstract

The livers of 345 autopsy cases of chronic liver disease were examined for macroregenerative nodule (MRN), a large nodular lesion more than 10 mm in diameter. A total of 86 lesions of MRN was found in 49 cases (14.2%): 32 were from 191 cases of hepatocellular carcinoma (HCC), 16 were from 148 cases of cirrhosis only, and one was from six cases of chronic hepatitis. The incidence (19.6%) and the size (12.1 mm) of MRN in macronodular type of cirrhosis were significantly higher and larger than those in other types of cirrhosis. Also, the average size of MRN lesions of cases with HCC (12 mm) was significantly larger than that of cases with cirrhosis only (10.5 mm). The incidence of liver cell dysplasia (LCD) in cases of MRN (67.3%) was significantly higher than that in cases without MRN (40.9%). The MRN lesions were divided into Type I and Type II, the latter having proliferative foci distinguishable from the surrounding tissue. Three of them contained atypical cells regarded as cancer. Type II lesions were larger in size, and cases with multiple MRN lesions were seen more frequently in cases of HCC. The average age of the patients with Type II lesion was 5 years older than those with Type I lesions. These findings suggest that MRN should not be ignored in the morphogenesis of HCC.

Entities:  

Mesh:

Year:  1988        PMID: 2825960     DOI: 10.1002/1097-0142(19880101)61:1<99::aid-cncr2820610117>3.0.co;2-u

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  24 in total

Review 1.  Approaches to the diagnosis of hepatocellular carcinoma.

Authors:  Morris Sherman
Journal:  Curr Gastroenterol Rep       Date:  2005-02

2.  Hyperintense cirrhotic nodules on MRI.

Authors:  S A Koslow; P L Davis; G B DeMarino; R L Peel; R L Baron; D H Van Thiel
Journal:  Gastrointest Radiol       Date:  1991

3.  Cytophotometric DNA analysis of adenomatous hyperplasia in cirrhotic livers.

Authors:  M Hoso; Y Nakanuma
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

4.  Classification tool for the systematic histological assessment of hepatocellular carcinoma, macroregenerative nodules, and dysplastic nodules in cirrhotic liver.

Authors:  A Quaglia; M A Jutand; A Dhillon; A Godfrey; R Togni; P Bioulac-Sage; C Balabaud; M Winnock; A P Dhillon
Journal:  World J Gastroenterol       Date:  2005-10-28       Impact factor: 5.742

Review 5.  Hepatic neoplasia: reflections and ruminations.

Authors:  K Aterman
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

6.  Management of adenomatous hyperplastic nodules in the cirrhotic liver: US follow-up or percutaneous alcohol ablation?

Authors:  R Lencioni; C Bartolozzi; D Caramella; G Di Coscio
Journal:  Abdom Imaging       Date:  1993

7.  Hepatitis C-associated hepatocellular carcinomas in non-cirrhotic livers.

Authors:  Matthew M Yeh; Hubert Darius-J Daniel; Michael Torbenson
Journal:  Mod Pathol       Date:  2009-11-20       Impact factor: 7.842

8.  Histopathological and morphometric analysis of atypical adenomatous hyperplasia of human cirrhotic livers.

Authors:  T Terada; K Ueda; Y Nakanuma
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

9.  Molecular profiling of hepatocellular carcinomas (HCC) using a large-scale real-time RT-PCR approach: determination of a molecular diagnostic index.

Authors:  Valérie Paradis; Ivan Bièche; Delphine Dargère; Ingrid Laurendeau; Christophe Laurent; Paulette Bioulac Sage; Claude Degott; Jacques Belghiti; Michel Vidaud; Pierre Bedossa
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

10.  Macro-regenerative nodules in biliary atresia: CT/MRI findings and their pathological relations.

Authors:  Jiun-Lung Liang; Yu-Fan Cheng; Allan-M Concejero; Tung-Liang Huang; Tai-Yi Chen; Leo-Leung-Chit Tsang; Hsin-You Ou
Journal:  World J Gastroenterol       Date:  2008-07-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.